Stockreport

LENZ Therapeutics Inc (LENZ) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF Net Product Revenue: Approximately $1.6 million in Q4 2025, the first quarter of product launch. Operating Expenses: Total Q4 operating expenses were approximately $4 [Read more]